Interestingly, while HDAC inhibitors have demonstrated therapeutic potential in treating neurodegenerative diseases like Alzheimer's (He et al. 2023), our results suggest that an alternative therapeutic strategy may be required for AMD. Here, HDAC9 is linked to age-related macular degeneration.